1
|
Song JA, Xu YF, Liu WQ, Xiao CW, Liu B, Carbonara U, Campi R, Zhu JG, Wang LH, Wu ZJ. Laparoendoscopic single-site radical nephrectomy for localized renal cancer: a descriptive research study with at least a 10-year follow-up. Transl Androl Urol 2023; 12:90-96. [PMID: 36760872 PMCID: PMC9906104 DOI: 10.21037/tau-22-863] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Accepted: 01/10/2023] [Indexed: 01/18/2023] Open
Abstract
Background Laparoendoscopic single-site (LESS) surgery is performed to further narrow the incisions and reduce tissue injury. It has been more than10 years since the surgery was first described. However, there is still no report on the results of 10-year follow-up. This study evaluated the use of long-term oncology and the renal outcomes of LESS radical nephrectomy (LESS-RN) in the treatment of localized renal cancer. Methods We retrospectively analyzed the clinical data of patients treated with LESS-RN at Changhai Hospital from 2009 to 2012. Patients with localized kidney cancer who were followed-up for at least 10 years were included in the study. The baseline data and major perioperative outcome variables were analyzed. Overall survival (OS) and cancer-specific survival (CSS) were calculated using the Kaplan-Meier method. Results A total of 48 patients were included in the study, which had a median follow-up of 11 years (interquartile range, 10.7-11.8 years). The 10-year OS and CSS rates were 87.5% [42/48; 95% confidence interval (CI): 0.778-0.972] and 97.9% (47/48; 95% CI: 0.937-1.021), respectively. At the most recent follow-up, there were 5 patients with a chronic kidney disease stage ≥3. Among these 5 patients, 3 developed uremia and required continuous dialysis. Conclusions For localized renal cancer, LESS-RN is safe and effective with excellent long-term oncology controllability and good functional outcomes. Prospective studies with large sample sizes need to be conducted to validate our results.
Collapse
Affiliation(s)
- Jia-Ao Song
- Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China
| | - Yi-Fan Xu
- Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China
| | - Wen-Qiang Liu
- Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China
| | - Cheng-Wu Xiao
- Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China
| | - Bing Liu
- Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China
| | - Umberto Carbonara
- Department of Emergency and Organ Transplantation-Urology, Andrology and Kidney Transplantation Unit, University of Bari, Bari, Italy;,European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group, Arnhem, The Netherlands
| | - Riccardo Campi
- European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group, Arnhem, The Netherlands;,Unit of Urological Robotic Surgery and Renal Transplantation, University of Florence, Careggi Hospital, Florence, Italy
| | - Jian-Guo Zhu
- Department of Urology, Guizhou Provincial People’s Hospital, Guiyang, China
| | - Lin-Hui Wang
- Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China
| | - Zhen-Jie Wu
- Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China;,European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group, Arnhem, The Netherlands
| |
Collapse
|